NASDAQ:NARI - US45332Y1091 - Common Stock
We assign a fundamental rating of 4 out of 10 to NARI. NARI was compared to 185 industry peers in the Health Care Equipment & Supplies industry. NARI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NARI is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -11.27% | ||
ROE | -18.07% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 86.82% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 11.25 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.77 | ||
Quick Ratio | 1.4 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 405.53 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 2971.47 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
79.97
+0.04 (+0.05%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 405.53 | ||
P/S | 8.15 | ||
P/FCF | 2971.47 | ||
P/OCF | 330.4 | ||
P/B | 10.77 | ||
P/tB | 60.34 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -11.27% | ||
ROE | -18.07% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 86.82% | ||
FCFM | 0.27% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 86.41% | ||
Cap/Sales | 2.19% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.77 | ||
Quick Ratio | 1.4 | ||
Altman-Z | 11.25 |